MMLP

MMLP screens optically cheap at a 0.1x price-to-sales and ~5x EV/EBITDA (operating income $48.9M + D&A $50.2M ≈ $99M against ~$516M enterprise value), but the cheapness is a function of where the capital structure sits, not undervalued equity. Total liabilities of $608M exceed total assets of $522M, so book equity is roughly negative $86M — the common units are a leveraged stub on top of $428M of long-term debt carrying a 7.66% weighted-average rate. That ~$33M annual interest load is precisely why operating income of $48.9M still produces a net loss, and the partnership has now lost money every year for five straight years (FY2021 through FY2025), with FY2025's -$14.7M the worst of the stretch (down 183% YoY). Revenue has eroded from $1.02B in FY2022 to $716M, and the FY2025 +1.2% uptick does not change the multi-year decline.

The balance sheet leaves almost no margin for error: cash and equivalents are a startling $49 thousand. The business is real and cash-generative — operating cash flow of $46.1M against $24.8M of capex leaves ~$21M of free cash flow, and capex was cut 41% — but that free cash is going to service and slowly pare debt (long-term debt down only 2.2%), not to unitholders. Management's January 2026 declaration of a $0.005 quarterly distribution ($0.02 annualized, under a 1% yield on a $2.26 unit) is the tell: capital is being preserved for the lenders, and the equity is along for the ride. Covenant compliance is affirmed, but the MD&A flags that borrowing capacity is itself gated by financial performance, and the 2028 Notes will eventually need refinancing into whatever rate environment exists then.